메뉴 건너뛰기




Volumn 25, Issue 3, 2007, Pages 513-515

Added VALUE of an ancillary study on ambulatory blood pressure monitoring

Author keywords

[No Author keywords available]

Indexed keywords

AMLODIPINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; VALSARTAN;

EID: 33846826990     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/HJH.0b013e32804955d6     Document Type: Editorial
Times cited : (2)

References (21)
  • 1
    • 0031690680 scopus 로고    scopus 로고
    • The Valsartan Antihypertensive Long-term Use Evaluation (VALUE) trial of cardiovascular events in hypertension. Rationale and design
    • for the VALUE Trial Group
    • Mann J, Julius S, for the VALUE Trial Group. The Valsartan Antihypertensive Long-term Use Evaluation (VALUE) trial of cardiovascular events in hypertension. Rationale and design. Blood Press 1998; 7:176-183.
    • (1998) Blood Press , vol.7 , pp. 176-183
    • Mann, J.1    Julius, S.2
  • 2
    • 2942635317 scopus 로고    scopus 로고
    • Outcomes in hypertensive patients at high cardiovascular risk treated with valsartan- or amlodipine-based regimens: VALUE, a randomised trial
    • Julius S, Kjeldsen SE, Weber M, Brunner HR, Ekman S, Hansson L, et al. Outcomes in hypertensive patients at high cardiovascular risk treated with valsartan- or amlodipine-based regimens: VALUE, a randomised trial. Lancet 2004; 363:2022-2031.
    • (2004) Lancet , vol.363 , pp. 2022-2031
    • Julius, S.1    Kjeldsen, S.E.2    Weber, M.3    Brunner, H.R.4    Ekman, S.5    Hansson, L.6
  • 3
    • 10744226529 scopus 로고    scopus 로고
    • VALUE Trial: Long-term blood pressure trends in 13 449 patients with hypertension and high cardiovascular risk
    • Julius S, Kjeldsen SE, Brunner H, Hansson L, Platt F, Ekman S, et al. VALUE Trial: long-term blood pressure trends in 13 449 patients with hypertension and high cardiovascular risk. Am J Hypertens 2003; 16:544-548.
    • (2003) Am J Hypertens , vol.16 , pp. 544-548
    • Julius, S.1    Kjeldsen, S.E.2    Brunner, H.3    Hansson, L.4    Platt, F.5    Ekman, S.6
  • 5
    • 0021745696 scopus 로고
    • Why do we need large, simple randomized trials?
    • Yusuf S, Collins R, Peto R. Why do we need large, simple randomized trials? Stat Med 1984; 3:409-422.
    • (1984) Stat Med , vol.3 , pp. 409-422
    • Yusuf, S.1    Collins, R.2    Peto, R.3
  • 6
    • 22544437310 scopus 로고    scopus 로고
    • Blood pressure reduction and cardiovascular prevention: An update including the 2003-2004 secondary prevention trials
    • Staessen JA, Li Y, Thijs L, Wang JG. Blood pressure reduction and cardiovascular prevention: an update including the 2003-2004 secondary prevention trials. Hypertens Res 2005; 28:385-407.
    • (2005) Hypertens Res , vol.28 , pp. 385-407
    • Staessen, J.A.1    Li, Y.2    Thijs, L.3    Wang, J.G.4
  • 8
    • 0033609526 scopus 로고    scopus 로고
    • Is pulse pressure useful in predicting risk for coronary heart disease? The Framingham Heart Study
    • Franklin SS, Khan SA, Wong ND, Larson MG, Levy D. Is pulse pressure useful in predicting risk for coronary heart disease? The Framingham Heart Study. Circulation 1999; 100:354-360.
    • (1999) Circulation , vol.100 , pp. 354-360
    • Franklin, S.S.1    Khan, S.A.2    Wong, N.D.3    Larson, M.G.4    Levy, D.5
  • 9
    • 33750190467 scopus 로고    scopus 로고
    • Valsartan/hydrochlorothiazide
    • Wagstaff AJ. Valsartan/hydrochlorothiazide. Drugs 2006; 66:1881-1901.
    • (2006) Drugs , vol.66 , pp. 1881-1901
    • Wagstaff, A.J.1
  • 10
    • 0034685168 scopus 로고    scopus 로고
    • Angiotensin II receptor antagonists
    • Burnier M, Brunner HR. Angiotensin II receptor antagonists. The Lancet 2000; 355:637-645.
    • (2000) The Lancet , vol.355 , pp. 637-645
    • Burnier, M.1    Brunner, H.R.2
  • 11
    • 0026563482 scopus 로고
    • Pharmacokinetics and pharmacodynamics of amlodipine
    • Abernethy DR. Pharmacokinetics and pharmacodynamics of amlodipine. Cardiology 1992; 80 (Suppl 1):31-36.
    • (1992) Cardiology , vol.80 , Issue.SUPPL. 1 , pp. 31-36
    • Abernethy, D.R.1
  • 14
    • 0031444869 scopus 로고    scopus 로고
    • Amlodipine lowers blood pressure without increasing sympathetic activity or activating the renin-angiotensin system in patients with essential hypertension
    • Sasaguri M, Matsumoto N, Noda K, Koga M, Kinoshita A, Ideishi M, et al. Amlodipine lowers blood pressure without increasing sympathetic activity or activating the renin-angiotensin system in patients with essential hypertension. Eur J Clin Pharmacol 1997; 53:197-201.
    • (1997) Eur J Clin Pharmacol , vol.53 , pp. 197-201
    • Sasaguri, M.1    Matsumoto, N.2    Noda, K.3    Koga, M.4    Kinoshita, A.5    Ideishi, M.6
  • 15
    • 0031941183 scopus 로고    scopus 로고
    • Evaluation of changes in sympathetic nerve activity and heart rate in essential hypertensive patients induced by amlodipine and nifedipine
    • Hamada T, Watanabe M, Kaneda T, Ohtahara A, Kinugawa T, Hisatome I, et al. Evaluation of changes in sympathetic nerve activity and heart rate in essential hypertensive patients induced by amlodipine and nifedipine. J Hypertens 1998; 16:111-118.
    • (1998) J Hypertens , vol.16 , pp. 111-118
    • Hamada, T.1    Watanabe, M.2    Kaneda, T.3    Ohtahara, A.4    Kinugawa, T.5    Hisatome, I.6
  • 16
    • 0032209587 scopus 로고    scopus 로고
    • Different effects of nifedipine and amlodipine on circulating catecholamine levels in essential hypertensive patients
    • de Champlain J, Karas M, Nguyen P, Cartier P, Wistaff R, Toal CB, et al. Different effects of nifedipine and amlodipine on circulating catecholamine levels in essential hypertensive patients. J Hypertens 1998; 16:1357-1369.
    • (1998) J Hypertens , vol.16 , pp. 1357-1369
    • de Champlain, J.1    Karas, M.2    Nguyen, P.3    Cartier, P.4    Wistaff, R.5    Toal, C.B.6
  • 17
    • 0033030487 scopus 로고    scopus 로고
    • Effects of amlodipine on sympathetic nerve traffic and baroreflex control of circulation in heart failure
    • Grassi G, Spaziani D, Seravalle G, Bertinieri G, Dell'Oro R, Cuspidi C, et al. Effects of amlodipine on sympathetic nerve traffic and baroreflex control of circulation in heart failure. Hypertension 1999; 33:671-675.
    • (1999) Hypertension , vol.33 , pp. 671-675
    • Grassi, G.1    Spaziani, D.2    Seravalle, G.3    Bertinieri, G.4    Dell'Oro, R.5    Cuspidi, C.6
  • 18
    • 21744446081 scopus 로고    scopus 로고
    • Superiority of ambulatory over clinic blood pressure measurement in predicting mortality. The Dublin Outcome Study
    • Dolan E, Stanton A, Thijs L, Hinedi K, Atkins N, McClory S, et al. Superiority of ambulatory over clinic blood pressure measurement in predicting mortality. The Dublin Outcome Study. Hypertension 2005; 46:156-161.
    • (2005) Hypertension , vol.46 , pp. 156-161
    • Dolan, E.1    Stanton, A.2    Thijs, L.3    Hinedi, K.4    Atkins, N.5    McClory, S.6
  • 20
    • 0035814961 scopus 로고    scopus 로고
    • Does the relation of blood pressure to coronary heart disease change with aging? The Framingham Heart Study
    • Franklin SS, Larson MG, Khan SA, Wong ND, Leip EP, Kannel WB, et al. Does the relation of blood pressure to coronary heart disease change with aging? The Framingham Heart Study. Circulation 2001; 103:1245-1249.
    • (2001) Circulation , vol.103 , pp. 1245-1249
    • Franklin, S.S.1    Larson, M.G.2    Khan, S.A.3    Wong, N.D.4    Leip, E.P.5    Kannel, W.B.6
  • 21
    • 0033546609 scopus 로고    scopus 로고
    • Predicting cardiovascular risk using conventional vs ambulatory blood pressure in older patients with systolic hypertension
    • Staessen JA, Thijs L, Fagard R, O'Brien ET, Clement D, de Leeuw PW, et al. Predicting cardiovascular risk using conventional vs ambulatory blood pressure in older patients with systolic hypertension. JAMA 1999; 282:539-546.
    • (1999) JAMA , vol.282 , pp. 539-546
    • Staessen, J.A.1    Thijs, L.2    Fagard, R.3    O'Brien, E.T.4    Clement, D.5    de Leeuw, P.W.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.